Paper39337461
New Insights into Mitochondria in Health and Diseases.
Li Y and 9 others. Int J Mol Sci, 2024. Cited by 40 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. New Insights into Mitochondria in Health and Diseases. Papers, record 39337461. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337461
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mitochondria | Major topic |
| Mitochondrial Diseases | Major topic |
| Humans | |
| Animals | |
| Neoplasms | |
| Energy Metabolism | |
| Reactive Oxygen Species |
Source PubMed
References127
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36,321,555 | Disrupting metformin adaptation of liver cancer cells by targeting the TOMM34/ATP5B axis. | EMBO Mol Med | 2022 | https://conductscience.org/library/papers/36321555 | PubMed |
| 2 | 37,047,492 | Inflammatory Processes in Alzheimer's Disease-Pathomechanism, Diagnosis and Treatment: A Review. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37047492 | PubMed |
| 3 | 35,851,420 | Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. | J Hematol Oncol | 2022 | https://conductscience.org/library/papers/35851420 | PubMed |
| 4 | 34,122,299 | Leber Hereditary Optic Neuropathy: Review of Treatment and Management. | Front Neurol | 2021 | https://conductscience.org/library/papers/34122299 | PubMed |
| 5 | 19,204,268 | Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A>G mtDNA mutation. | Neurology | 2009 | https://conductscience.org/library/papers/19204268 | PubMed |
| 6 | 35,682,884 | AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682884 | PubMed |
| 7 | 1,576,071 | A comparison of acipimox and nicotinic acid in type 2b hyperlipidaemia. | Br J Clin Pharmacol | 1992 | https://conductscience.org/library/papers/1576071 | PubMed |
| 8 | 27,259,056 | The Epidemiology of Leber Hereditary Optic Neuropathy in the North East of England. | Am J Hum Genet | 2016 | https://conductscience.org/library/papers/27259056 | PubMed |
| 9 | 16,604,074 | High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. | Nat Genet | 2006 | https://conductscience.org/library/papers/16604074 | PubMed |
| 10 | 38,982,016 | Mitochondrial targeted antioxidants as potential therapy for huntington's disease. | Pharmacol Rep | 2024 | https://conductscience.org/library/papers/38982016 | PubMed |
| 11 | 27,930,341 | Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/27930341 | PubMed |
| 12 | 38,286,821 | Obesity causes mitochondrial fragmentation and dysfunction in white adipocytes due to RalA activation. | Nat Metab | 2024 | https://conductscience.org/library/papers/38286821 | PubMed |
| 13 | 27,814,641 | The little big genome: the organization of mitochondrial DNA. | Front Biosci (Landmark Ed) | 2017 | https://conductscience.org/library/papers/27814641 | PubMed |
| 14 | 20,871,098 | Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. | Hum Mol Genet | 2010 | https://conductscience.org/library/papers/20871098 | PubMed |
| 15 | 16,399,671 | Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. | J Neurosci | 2006 | https://conductscience.org/library/papers/16399671 | PubMed |
| 16 | 36,810,524 | Signaling pathways in Parkinson's disease: molecular mechanisms and therapeutic interventions. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/36810524 | PubMed |
| 17 | 21,806,499 | Mechanisms of mitochondrial diseases. | Ann Med | 2012 | https://conductscience.org/library/papers/21806499 | PubMed |
| 18 | 23,422,877 | Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. | Neurochem Int | 2013 | https://conductscience.org/library/papers/23422877 | PubMed |
| 19 | 37,923,251 | Elamipretide Topical Ophthalmic Solution for the Treatment of Subjects with Leber Hereditary Optic Neuropathy: A Randomized Trial. | Ophthalmology | 2024 | https://conductscience.org/library/papers/37923251 | PubMed |
| 20 | 28,004,807 | Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. | Nat Rev Cardiol | 2017 | https://conductscience.org/library/papers/28004807 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,942,175 | Mitochondrial Genomic Variation in Rare and Metabolic Diseases: From Heteroplasmy to Precision Medicine. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42942175 | PubMed |
| 42,866,626 | Recent Advances in Mitochondria-Targeted Delivery Strategies for Ischemic Stroke Therapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42866626 | PubMed |
| 42,524,031 | Eplerenone Attenuates Hepatic Oxidative Stress and Mitochondrial Dysfunction Following Renal Ischemia-Reperfusion Injury in Rats. | Adv Pharm Bull | 2026 | https://conductscience.org/library/papers/42524031 | PubMed |
| 42,346,399 | Identification and Transcriptomic Analysis of Mitochondria-Related Gene Signatures in Obesity. | Metabolites | 2026 | https://conductscience.org/library/papers/42346399 | PubMed |
| 42,136,573 | Molecular pathways, tissue-specific roles, and therapeutic opportunities in mitochondrial resilience-based strategies for insulin resistance. | Front Clin Diabetes Healthc | 2026 | https://conductscience.org/library/papers/42136573 | PubMed |
| 42,068,434 | Hepatoprotective Mechanisms of Lactiplantibacillus plantarum SCS7 Cell-Free Extract Against Aflatoxin B1 Toxicity. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/42068434 | PubMed |
| 41,963,964 | Mitochondrial dysfunction in neonatal brain injury: from molecular mechanisms to therapeutic interventions. | J Transl Med | 2026 | https://conductscience.org/library/papers/41963964 | PubMed |
| 41,854,947 | Beyond Supportive Care: Mitochondria as a Strategic Therapeutic Avenue in Acute Pancreatitis. | Dig Dis Sci | 2026 | https://conductscience.org/library/papers/41854947 | PubMed |
| 41,827,730 | Metal Ion-Mediated Regulation of Cell Fate: A Novel Strategy for Synergy with Radiotherapy and Immunotherapy. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41827730 | PubMed |
| 41,816,588 | Identification of mitochondrial-related subtypes and development of a prognostic model for pancreatic ductal adenocarcinoma. | J Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/41816588 | PubMed |
| 41,503,358 | No effect of pyrroloquinoline quinone on mouse body weight and energy metabolism with the concomitant increase in mitochondrial biogenesis and antioxidant ability. | Metabol Open | 2026 | https://conductscience.org/library/papers/41503358 | PubMed |
| 41,496,907 | The pivotal role of mitochondria in osteoporosis: From pathogenesis to future therapies. | Biochem Biophys Rep | 2026 | https://conductscience.org/library/papers/41496907 | PubMed |
| 41,439,139 | Unraveling Parkinson's disease: The mystery of mitochondria and the role of aging. | Genes Dis | 2026 | https://conductscience.org/library/papers/41439139 | PubMed |
| 41,393,082 | Mitochondria-Targeted Nanosystems in the Treatment of Central Nervous System Diseases. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/41393082 | PubMed |
| 41,240,149 | Mitochondrial Calcium Channels and MAM Interaction in Calcium Homeostasis Dysregulation in Parkinson's Disease. | Neurochem Res | 2025 | https://conductscience.org/library/papers/41240149 | PubMed |
| 41,030,279 | Mitochondrial and photosynthetic therapy: A crucial strategy for remodeling cellular metabolic function. | Bioeng Transl Med | 2025 | https://conductscience.org/library/papers/41030279 | PubMed |
| 41,029,932 | Mitochondria as a Therapeutic Target in Metabolic Disorders. | Mini Rev Med Chem | 2026 | https://conductscience.org/library/papers/41029932 | PubMed |
| 40,997,805 | The multiomics blueprint of the individual with the most extreme lifespan. | Cell Rep Med | 2025 | https://conductscience.org/library/papers/40997805 | PubMed |
| 40,701,842 | Hemistepsin A induces apoptosis by modulating the reactive oxygen species-dependent PI3K/Akt signaling pathway in human lung carcinoma A549 cells. | Korean J Physiol Pharmacol | 2025 | https://conductscience.org/library/papers/40701842 | PubMed |
| 40,516,788 | Analysis of mitochondrial membrane potential, ROS, and calcium. | Mol Cells | 2025 | https://conductscience.org/library/papers/40516788 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337461
GET https://conductscience.org/api/papers/v1/39337461/references?page=2